Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen

<p>Ovarian epithelial dysplasia was initially described in material from prophylactic oophorectomies for BReast CAncer gene (BRCA) mutation. Similar histopathological abnormalities have been revealed after ovulation stimulation. Given that tamoxifen (TAM) has a clomid-like effect and is someti...

Full description

Bibliographic Details
Main Authors: G. Chene, N. Radosevic-Robin, A.S. Tardieu, A. Cayre, I. Raoelfils, P. Dechelotte, J. Dauplat, F. Penault Llorca
Format: Article
Language:English
Published: PAGEPress Publications 2014-04-01
Series:European Journal of Histochemistry
Subjects:
Online Access:http://www.ejh.it/index.php/ejh/article/view/2251
_version_ 1828256428387729408
author G. Chene
N. Radosevic-Robin
A.S. Tardieu
A. Cayre
I. Raoelfils
P. Dechelotte
J. Dauplat
F. Penault Llorca
author_facet G. Chene
N. Radosevic-Robin
A.S. Tardieu
A. Cayre
I. Raoelfils
P. Dechelotte
J. Dauplat
F. Penault Llorca
author_sort G. Chene
collection DOAJ
description <p>Ovarian epithelial dysplasia was initially described in material from prophylactic oophorectomies for BReast CAncer gene (BRCA) mutation. Similar histopathological abnormalities have been revealed after ovulation stimulation. Given that tamoxifen (TAM) has a clomid-like effect and is sometimes used to induce ovulation, we studied the morphological features and immunohistochemical expression patterns of neoplasia-associated markers in adnexectomies previously exposed to TAM for breast cancer. We blindly reviewed 173 histopathological slides of adnexectomies according to three groups – oophorectomie sassociated with TAM exposure (n=42), oophorectomies associated with clomiphene exposure (n=15) and a spontaneously fertile non cancerous control group (n=116). Morphological features (with an ovarian and tubal dysplasia scoring system) and immunohistochemical expression patterns of Ki-67, p53 and Aldehyde dehydrogenase 1 (ALDH1 is an enzyme significantly associated with earlystage ovarian cancer) were evaluated and correlated. Mean tubal dysplasia score was significantly higher in the TAM group and clomiphene group than in controls (respectively 7.8 <em>vs</em> 3.5, P&lt;0.007 and 6.8 <em>vs</em> 3.5, P=0.008). There is no statistical difference for the ovarian score in TAM group in comparison with the control group whereas we found a significant score for clomiphen group (6.5, P=0.009). Increased ALDH1 expression was observed in the two exposed group whereas expression patterns of Ki67 and p53 were moderate. Interestingly, ALDH1 expression was low in non-dysplastic epithelium, high in dysplasia, and constantly low in the two carcinoma. Furthermore, we confirm our previous results showing that ALDH1 may be a useful tissue biomarker in the subtle histopathological diagnosis of tubo-ovarian dysplasia.</p>
first_indexed 2024-04-13T02:28:04Z
format Article
id doaj.art-f10e8ba65c9b43d4a7abe76899756e4a
institution Directory Open Access Journal
issn 1121-760X
2038-8306
language English
last_indexed 2024-04-13T02:28:04Z
publishDate 2014-04-01
publisher PAGEPress Publications
record_format Article
series European Journal of Histochemistry
spelling doaj.art-f10e8ba65c9b43d4a7abe76899756e4a2022-12-22T03:06:43ZengPAGEPress PublicationsEuropean Journal of Histochemistry1121-760X2038-83062014-04-0158210.4081/ejh.2014.22511395Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifenG. Chene0N. Radosevic-Robin1A.S. Tardieu2A. Cayre3I. Raoelfils4P. Dechelotte5J. Dauplat6F. Penault Llorca7Centre Jean Perrin, ERTICA Research TeamCentre Jean Perrin, ERTICA Research TeamCentre Jean Perrin, ERTICA Research TeamCentre Jean Perrin, ERTICA Research TeamCentre Jean Perrin, ERTICA Research TeamCHU Estaing, Clermont-FerrandCentre Jean PerrinCentre Jean Perrin<p>Ovarian epithelial dysplasia was initially described in material from prophylactic oophorectomies for BReast CAncer gene (BRCA) mutation. Similar histopathological abnormalities have been revealed after ovulation stimulation. Given that tamoxifen (TAM) has a clomid-like effect and is sometimes used to induce ovulation, we studied the morphological features and immunohistochemical expression patterns of neoplasia-associated markers in adnexectomies previously exposed to TAM for breast cancer. We blindly reviewed 173 histopathological slides of adnexectomies according to three groups – oophorectomie sassociated with TAM exposure (n=42), oophorectomies associated with clomiphene exposure (n=15) and a spontaneously fertile non cancerous control group (n=116). Morphological features (with an ovarian and tubal dysplasia scoring system) and immunohistochemical expression patterns of Ki-67, p53 and Aldehyde dehydrogenase 1 (ALDH1 is an enzyme significantly associated with earlystage ovarian cancer) were evaluated and correlated. Mean tubal dysplasia score was significantly higher in the TAM group and clomiphene group than in controls (respectively 7.8 <em>vs</em> 3.5, P&lt;0.007 and 6.8 <em>vs</em> 3.5, P=0.008). There is no statistical difference for the ovarian score in TAM group in comparison with the control group whereas we found a significant score for clomiphen group (6.5, P=0.009). Increased ALDH1 expression was observed in the two exposed group whereas expression patterns of Ki67 and p53 were moderate. Interestingly, ALDH1 expression was low in non-dysplastic epithelium, high in dysplasia, and constantly low in the two carcinoma. Furthermore, we confirm our previous results showing that ALDH1 may be a useful tissue biomarker in the subtle histopathological diagnosis of tubo-ovarian dysplasia.</p>http://www.ejh.it/index.php/ejh/article/view/2251Ovarian carcinogenesisovarian dysplasiaprophylactic oophorectomyALDH1p53.
spellingShingle G. Chene
N. Radosevic-Robin
A.S. Tardieu
A. Cayre
I. Raoelfils
P. Dechelotte
J. Dauplat
F. Penault Llorca
Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen
European Journal of Histochemistry
Ovarian carcinogenesis
ovarian dysplasia
prophylactic oophorectomy
ALDH1
p53.
title Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen
title_full Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen
title_fullStr Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen
title_full_unstemmed Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen
title_short Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen
title_sort morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen
topic Ovarian carcinogenesis
ovarian dysplasia
prophylactic oophorectomy
ALDH1
p53.
url http://www.ejh.it/index.php/ejh/article/view/2251
work_keys_str_mv AT gchene morphologicalandimmunohistochemicalstudyofovarianandtubaldysplasiaassociatedwithtamoxifen
AT nradosevicrobin morphologicalandimmunohistochemicalstudyofovarianandtubaldysplasiaassociatedwithtamoxifen
AT astardieu morphologicalandimmunohistochemicalstudyofovarianandtubaldysplasiaassociatedwithtamoxifen
AT acayre morphologicalandimmunohistochemicalstudyofovarianandtubaldysplasiaassociatedwithtamoxifen
AT iraoelfils morphologicalandimmunohistochemicalstudyofovarianandtubaldysplasiaassociatedwithtamoxifen
AT pdechelotte morphologicalandimmunohistochemicalstudyofovarianandtubaldysplasiaassociatedwithtamoxifen
AT jdauplat morphologicalandimmunohistochemicalstudyofovarianandtubaldysplasiaassociatedwithtamoxifen
AT fpenaultllorca morphologicalandimmunohistochemicalstudyofovarianandtubaldysplasiaassociatedwithtamoxifen